# Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy

> **NCT07245095** · PHASE2 · RECRUITING · sponsor: **Hospital General de Mexicali** · enrollment: 132 (estimated)

## Conditions studied

- Esophagogastroduodenoscopy
- Simethicone
- N-Acetylcysteine
- Premedication
- Visualization
- Esophagogastroduodensocopy (EGD) Procedure
- Placebo - Control
- Gastritis Associated With Helicobacter Pylori
- Tumor Gastric
- Lesions in the Esophagus, Stomach, Duodenum or Rectum

## Interventions

- **DRUG:** Premedication with n-acetylcysteine
- **DRUG:** Placebo (drinking water)
- **DRUG:** Premedication with simethicone

## Key facts

- **NCT ID:** NCT07245095
- **Lead sponsor:** Hospital General de Mexicali
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-12
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07245095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07245095, "Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07245095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
